|
1) Risdon RA, Sloper JC, DeWardener HE. Relationship between renal function and histological changes found in specimens from patients with persistent glomerular nephritis. Lancet. 1968; 2: 363-6
|
|
|
|
|
2) Christensen EI, Verroust PJ. Interstitial fibrosis: tubular hypothesis versus glomerular hypothesis. Kidney Int. 2008; 74: 1233-6
|
|
|
|
|
3) 松尾清一. タンパク尿による尿細管間質病変. 医学のあゆみ. 2005; 212: 671-4
|
|
|
|
|
4) 松尾清一, 丸山彰一. ｢尿細管間質病変｣尿細管間質病変の発症と進展 腎尿細管間質障害の進展における接着分子, サイトカイン, ケモカインの役割. 腎と透析. 2003; 55: 445-50
|
|
|
|
|
|
5) Kriz W, LeHir M. Pathways to nephron loss starting from glomerular diseases-insights from animal models. Kidney Int. 2005; 67: 404-19
|
|
|
|
|
|
6) Kang DH, Hughes J, Mazzali M, et al. Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol. 2001; 12: 1448-57
|
|
|
|
|
|
7) Kerjaschki D, Regele HM, Moosberger I, et al. Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J Am Soc Nephrol. 2004; 15: 603-12
|
|
|
|
|
|
8) Sakamoto I, Ito Y, Mizuno M, et al. Lymphatic vessels develop during tubulointerstitial fibrosis. Kidney Int. 2009; 75: 828-38
|
|
|
|
|
|
9) Morita Y, Ikeguchi H, Nakamura J, et al. Complement activation products in the urine from proteinuric patients. J Am Soc Nephrol. 2000; 11: 700-7
|
|
|
|
|
|
10) Vieyra MB, Heeger PS. Novel aspect of complement in kidney injury. Kidney Int. 2010; 77: 495-9
|
|
|
|
|
|
11) Pratt JR, Basheer SA, Sacks SH. Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med. 2002; 8: 582-7
|
|
|
|
|
|
12) 水野正司, 湯沢由紀夫, 松尾清一. これだけは知っておきたい分子腎臓学 2007: C5a. 腎と透析. 2007; 63: 580-2
|
|
|
|
|
|
13) Sheerin NS, Risley P, Abe K, et al. Synthesis of complement protein C3 in the kidney is an important mediator of local tissue injury. FASEB J. 2008; 22: 1065-72
|
|
|
|
|
|
14) Tang Z, Lu B, Hatch E, et al. C3a mediates epithelial-to-mesenchymal transition in proteinuric nephropathy. J Am Soc Nephrol. 2009; 20: 593-603
|
|
|
|
|
|
15) de Brito-Ashurst I, Varagunam M, Raftery MJ, et al. Bicarbonate supplementation slows progression of CKD and improves nutritional status. J Am Soc Nephrol. 2009; 20: 2075-84
|
|
|
|
|
|
16) Nath KA, Hostetter MK, Hostetter TH. Pathophysiology of chronic tubulo-interstitial disease in rats. Interactions of dietary acid load, ammonia, and complement component C3. J Clin Invest. 1985; 76: 667-75
|
|
|
|
|
|
17) Mahajan A, Simoni J, Sheather SJ, et al. Daily oral sodium bicarbonate preserves glomerular filtration rate by slowing its decline in early hypertensive nephropathy. Kidney Int. 2010; 78: 303-9
|
|
|
|
|
|
18) Anders HJ. Toll-like receptors and danger signaling in kidney injury. J Am Soc Nephrol. 2010; 21: 1270-4
|
|
|
|
|
|
19) Gluba A, Banach M, Hannam S, et al. The role of Toll-like receptors in renal diseases. Nat Rev Nephrol. 2010; 6: 224-35
|
|
|
|
|
|
20) Tsuboi N, Yoshikai Y, Matsuo S, et al. Roles of toll-like receptors in C-C chemokine production by renal tubular epithelial cells. J Immunol. 2002; 169: 2026-33
|
|
|
|
|
|
21) Wu H, Ma J, Wang P, et al. High-mobility group box1 contributes to kidney ischemia reperfusion injury through TLR4 signaling. J Immunol. 2010; 185: 3401-7
|
|
|
|
|
|
22) Zhang B, Ramesh G, Uematsu S, et al. TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity. J Am Soc Nephrol. 2008; 19: 923-32
|
|
|
|
|
|
23) Urahama Y, Ohsaki Y, Fujita Y, et al. Lipid droplet-associated proteins protect renal tubular cells from fatty acid-induced apoptosis. Am J Pathol. 2008; 173: 1286-94
|
|
|
|
|
|
24) Humphreys BD, Lin SL, Kobayashi A, et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol. 2009; 176: 85-97
|
|
|
|
|
|
25) 丸山彰一, 尾崎武徳. AKIと間葉系幹細胞―臨床応用可能な腎保護療法の開発をめざして. 医学のあゆみ. 2009; 231: 158-62
|
|
|
|
|
|
26) Guo JK, Cantley LG. Cellular maintenance and repair of the kidney. Annu Rev Physiol. 2010; 72: 357-76
|
|
|
|
|